Showing results (101-110 of 142) with videos related to

Sort By:
Pageof 15
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 2, 2015
Genetic Engineering of T Cells to Target HERV-K, an Ancient Retrovirus on MelanomaJanani Krishnamurthy, Brian A Rabinovich, Tiejuan Mi, et al.
Cancer Research|March 17, 2007
Combining adoptive cellular and immunocytokine therapies to improve treatment of B-lineage malignancyHarjeet Singh, Lisa Marie Serrano, Timothy Pfeiffer, et al.
Oncoimmunology|August 16, 2019
Percutaneous BCG enhances innate effector antitumor cytotoxicity during treatment of bladder cancer: a translational clinical trialNiannian Ji, Neelam Mukherjee, Edwin E Morales, et al.
Human Gene Therapy|August 28, 2013
Modification of hematopoietic stem/progenitor cells with CD19-specific chimeric antigen receptors as a novel approach for cancer immunotherapySatiro Nakamura De Oliveira, Christine Ryan, Francesca Giannoni, et al.
Scientific Reports|February 23, 2012
Adoptive T-cell therapy improves treatment of canine non-Hodgkin lymphoma post chemotherapyColleen M O'Connor, Sabina Sheppard, Cassie A Hartline, et al.
Cancer Research|September 3, 2015
Tuning Sensitivity of CAR to EGFR Density Limits Recognition of Normal Tissue While Maintaining Potent Antitumor ActivityHillary G Caruso, Lenka V Hurton, Amer Najjar, et al.
Oncoimmunology|December 22, 2016
Targeting B-cell malignancies through human B-cell receptor specific CD4<sup>+</sup> T cellsJinsheng Weng, Flavio Egidio Baio, Kelsey E Moriarty, et al.
Plos One|January 27, 2012
Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cellsCecele J Denman, Vladimir V Senyukov, Srinivas S Somanchi, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 17, 2016
Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cellsLenka V Hurton, Harjeet Singh, Amer M Najjar, et al.
Nature Communications|August 8, 2014
Recurrent ESR1-CCDC170 rearrangements in an aggressive subset of oestrogen receptor-positive breast cancersJamunarani Veeraraghavan, Ying Tan, Xi-Xi Cao, et al.
Pageof 15